Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Ozempic GoodRx vs Savings Card: Which Is Cheaper in 2026?
articleThere is no single GoodRx price for Ozempic. There is a manufacturer self-pay ladder that steps by dose and fill count, an older retail coupon that runs far higher, and a separate oral tier, and none of them is the manufacturer savings card. This guide separates them and routes you to the one your coverage actually allows.
Ozempic Cost 2026: List Price, Insurance, Self-Pay
articleThis Ozempic-specific cost guide walks the list price, commercial insurance, Medicare Part D, and the 2026 NovoCare self-pay ladder, plus why the diabetes-versus-weight-loss distinction drives most of what you actually pay.